Trans-catheter mitral valve implantation for mitral regurgitation: clinical case description and literature review. Issue 2 (February 2016)

• Record Type: Journal Article
• Authors: Romeo, Francesco; Cammalleri, Valeria; Ruvolo, Giovanni; Quadri, Arshad; De Vico, Pasquale; Muscoli, Saverio; Marchei, Massimo; Meloni, Sabrina; Conti, Fabio; Ussia, Gian Paolo
• Is Part Of: Journal of cardiovascular medicine. Volume 17:Issue 2(2016:Feb.)
• Publication Date: 2016-02
• Subjects: mitral anatomy -- mitral regurgitation -- trans-catheter mitral valve implantation; Cardiology -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; Cardiology -- Periodicals; Cardiovascular Diseases -- Periodicals; 616.1005
• DOI: 10.2459/JCM.0000000000000328
• Languages: English
• ISSNs: 1558-2027

Abstract

Abstract : Trans-catheter mitral valve implantation (TMVI) is actually the most attractive technique for treating patients with severe mitral regurgitation, who are denied surgical therapy. Recently, trans-catheter implantation of aortic biological prosthesis in mitral position has been done in compassionate cases, and very few experiences of TMVI in native non-calcified valves have been recently reported in very-high-risk patients, mainly with functional mitral regurgitation. Here, we report our case of TMVI using the second-generation CardiAQ prostheisis (CardiAQ Valve Technologies, Irvine, California, USA), reviewing the current state of the art.